Details of the Drug

General Information of Drug (ID: DMQ8BA6)

• Drug Name: Tuberculosis vaccine
• Synonyms: RBCG30, UCLA; Tuberculosis vaccine, UCLA; Tuberculosis vaccine, University of California LosAngeles; RBCG30, UCLA/Aeras; Subunit TB vaccine, ID Vaccine/Aventis Pasteur; Subunit TB vaccine, ID Vaccine/PMC; TB subunit vaccine, ID Vaccine/Aventis Pasteur; TB subunit vaccine, ID Vaccine/PMC; Tuberculosis vaccine, ID Vaccine/Aventis Pasteur; Tuberculosis vaccine, ID Vaccine/PMC; Tuberculosis vaccine, UCLA/Aeras; Vaccine (TB), ID Vaccine/Aventis Pasteur; Vaccine (TB), ID Vaccine/Pasteur Merieux Connaught; Vaccine (tuberculosis), ID Vaccine/Aventis Pasteur; Vaccine (tuberculosis), ID Vaccine/PMC

Indication

Disease Entry	ICD 11	Status	REF
Tuberculosis	1B10-1B1Z	Phase 2	[1]
Mycobacterium infection	1B10-1B21	Phase 1	[2]

• Cross-matching ID: TTD ID: D0VH0X
• Repurposed Drugs (RPD): Click to Jump to the Detailed RPD Information of This Drug

References

• [1] Clinical pipeline report, company report or official report of Aerus Global TB Vaccine Foundation.
• [2] New vaccine shows promise as stronger weapon against both tuberculosis and leprosy. Health + Behavior. Enrique Rivero, August 19, 2014.